NCT06207188 Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters
| NCT ID | NCT06207188 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Thyroid Gland Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 650 participants |
| Start Date | 2009-05-17 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 650 participants in total. It began in 2009-05-17 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to identify and differentiate thyroid nodules by acoustic imaging and viscoelastic parameters.
Eligibility Criteria
Inclusion Criteria: * \* Male and female patient volunteers ages 8 and up who are suspicious for thyroid cancer * Patients who have palpable and sonographically detectable lymph nodes or nonthyroidal neck masses and are referred to Radiology Department or Endocrinology for fine-needle aspiration biopsy (FNAB) * Patients 18 and up who were previously diagnosed with thyroid cancer and treated with thyroidectomy and recently diagnosed as having recurrence nodes on thyroid bed or on their neck Exclusion Criteria: * Because thyroid cancer is rare under the age of 8 years, children younger than this age are excluded from the study * Having FNAB or surgical biopsy on thyroid in less than two weeks for thyroid nodule detection group * Having FNAB or surgical biopsy on cervical lymph nodes or non- thyroidal masses for this group of patients
Contact & Investigator
Azra Alizad, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic in Rochester
Frequently Asked Questions
Who can join the NCT06207188 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, studying Thyroid Gland Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06207188 currently recruiting?
Yes, NCT06207188 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT06207188 trial being conducted?
This trial is being conducted at Scottsdale, United States, Jacksonville, United States, Rochester, United States.
Who is sponsoring the NCT06207188 clinical trial?
NCT06207188 is sponsored by Mayo Clinic. The principal investigator is Azra Alizad, MD at Mayo Clinic in Rochester. The trial plans to enroll 650 participants.